🔎 Trials Near Me

Home › Kanser sa Ulo at Leeg › Massachusetts

Pag-aaral pangklinika para sa Kanser sa Ulo at Leeg sa Massachusetts

24 pag-aaral para sa Kanser sa Ulo at Leeg ang naghahanap ng mga kalahok sa mga site sa Massachusetts.

Mga Lungsod sa Massachusetts

Opisyal na teksto ng pag-aaral (English)

The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)

  • Massachusetts General Hospital, Boston
  • Dana Farber Cancer Institute, Boston
Nagre-recruitPhase 1/2
Edad 12 pataas · Lahat ng kasarian · Na-update Okt 2, 2026 · NCT04585750

FORTIFI-HN01: A Study of Ficerafusp Alfa (BCA101) or Placebo in Combination With Pembrolizumab in First-Line PD-L1-pos, R or M HNSCC

  • Site #0131, Boston
  • Site#0101, Boston
Nagre-recruitPhase 2/3
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 2, 2026 · NCT06788990

Distance-Based Exercise to Preserve Function and Prevent Disability

  • Dana-Farber Cancer Institute, Boston
Nagre-recruit
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 2, 2026 · NCT07059884

A Study to Learn About the Study Medicine Called PF-08046876 in People With Advanced Solid Tumors

  • Brigham and Women's Hospital, Boston
  • Dana-Farber Cancer Institute, Boston
  • Dana-Farber Cancer Institute - Chestnut Hill, Newton
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 1, 2026 · NCT07090499

First in Human Study of TUB-030 in Patients With Advanced Solid Tumors

  • Massachusetts General Hospital, Boston
  • Dana Farber Cancer Institute, Boston
Nagre-recruitPhase 1/2
Edad 18 pataas · Lahat ng kasarian · Na-update Set 11, 2026 · NCT06657222

Toripalimab With Chemotherapy for Sinus Cancer

  • Brigham and Women's Hospital, Boston
  • Dana-Farber Cancer Institute, Boston
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Ago 31, 2026 · NCT06940180

PD-L1 t-haNK, NAI IL-15sa and Cetuximab for Recurrent, Metastatic HNSCC

  • Brigham and Women's Hospital, Boston
  • Dana Farber Cancer Institute, Boston
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Ago 18, 2026 · NCT06239220

A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors

  • Massachusetts General Hospital Cancer Center, Boston
Nagre-recruitPhase 1/2
Edad 18 pataas · Lahat ng kasarian · Na-update Ago 11, 2026 · NCT05592626

Jump: MR Simulation For Radiation Therapy Master Protocol

  • Brigham and Women Hospital, Boston
  • Dana Farber Cancer Institute, Boston
Nagre-recruit
Edad 18 pataas · Lahat ng kasarian · Na-update Hul 20, 2026 · NCT04545957

PDT For Induction Therapy For Head And Neck Cancer

  • Massachusetts General Hospital, Boston
  • Dana-Farber Cancer Institute, Boston
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Hul 14, 2026 · NCT07214987

First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors

  • Massachusetts General Hospital, Boston
  • Dana-Farber Cancer Institute, Boston
Nagre-recruitPhase 1/2
Edad 18 pataas · Lahat ng kasarian · Na-update Hul 7, 2026 · NCT05768139

Clonal Hematopoiesis Chemotherapy and Radiation Effects Study

  • Dana-Farber Cancer Institute, Boston
Nagre-recruitObservasyonal na pag-aaral
Edad 18 pataas · Lahat ng kasarian · Na-update Hun 30, 2026 · NCT07675967

Phase 1/2 Study of ETX-636 in Participants With Advanced Solid Tumors

  • Beth Israel Deaconess Medical Center, Boston
  • Dana-Farber Cancer Institute, Boston
Nagre-recruitPhase 1/2
Edad 18 pataas · Lahat ng kasarian · Na-update Hun 23, 2026 · NCT06993844

Preoperative Pembrolizumab and Chemotherapy in Resectable, Recurrent HNSCC

  • Brigham and Women's Hospital, Boston
  • Dana-Farber Cancer Institute, Boston
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Hun 23, 2026 · NCT05726370

A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements

  • Massachusetts General Hospital,, Boston
Nagre-recruitPhase 1/2
Edad 12 pataas · Lahat ng kasarian · Na-update May 27, 2026 · NCT03093116

A Study of Dostarlimab vs Placebo After Chemoradiation in Adult Participants With Locally Advanced Unresected Head and Neck Squamous Cell Carcinoma

  • GSK Investigational Site, Worcester
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update May 26, 2026 · NCT06256588

Dose Escalation and Dose Expansion Study of MDX2001 in Patients With Advanced Solid Tumors

  • Massachusetts General Hospital, Boston
Nagre-recruitPhase 1/2
Edad 18 pataas · Lahat ng kasarian · Na-update May 6, 2026 · NCT06239194

Study of De_Intensified Postoperative Radiation Therapy for HPV Associated Oropharyngeal Squamous Cell Carcinoma

  • Dana Farber Cancer Institute, Boston
Nagre-recruit
Edad 18 pataas · Lahat ng kasarian · Na-update Mar 13, 2026 · NCT03875716

Stereotactic MRI-guided Focused Ultrasound Mesencephalotomy

  • Brigham and Women's Hospital, Boston
Nagre-recruit
Edad 18 hanggang 85 · Lahat ng kasarian · Na-update Peb 12, 2026 · NCT07405645

Drug Screening Using Novel IMD in Salivary and Head and Neck Cancers

  • Brigham and Women's Hospital, Boston
  • Dana Farber Cancer Institute, Boston
Nagre-recruitMaagang Phase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Ene 26, 2026 · NCT05553782

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

  • Massive Bio SYNERGY-AI site, Worcester
Nagre-recruitObservasyonal na pag-aaral
Lahat ng edad · Lahat ng kasarian · Na-update Okt 28, 2025 · NCT03452774

A Study to Evaluate TROP2 ADC LCB84 Single Agent and in Combination With an Anti-PD-1 Ab in Advanced Solid Tumors

  • Dana Farber Cancer Institute, Boston
Nagre-recruitPhase 1/2
Edad 18 pataas · Lahat ng kasarian · Na-update Set 24, 2025 · NCT05941507

Study of Safety and Tolerability of BCA101 Monotherapy and in Combination Therapy in Patients With EGFR-driven Advanced Solid Tumors

  • Dana Farber/Partners Cancer Care Inc, Boston
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Ago 15, 2025 · NCT04429542

Comprehensive Outcomes for After Cancer Health

  • Dana Farber Cancer Institute, Boston
Nagre-recruitMalugod na tinatanggap ang malusog na boluntaryo
Edad 18 pataas · Lahat ng kasarian · Na-update Dis 11, 2024 · NCT05349227

Mula sa ClinicalTrials.gov, na-kuha noong Okt 6, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.